Clinical research

Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT)

EuroIntervention 2012;8:945-954. DOI: 10.4244/EIJV8I8A144

Joanna  J. Wykrzykowska
Joanna J. Wykrzykowska1,3, MD; Roberto Diletti1, MD; Juan Luis Gutierrez-Chico1, MD, PhD; Robert Jan van Geuns1, MD, PhD; Wim J. van der Giessen1, MD, PhD; Steven Ramcharitar1, MD, PhD; H. Eric Duckers1, MD, PhD; Carl Schultz1, MD, PhD; Pim de Feyter1, MD, PhD; Martin van der Ent1, MD, PhD; Evelyn Regar1, MD, PhD; Peter de Jaegere1, MD, PhD; Hector M. Garcia-Garcia1, MD, PhD; Rawindra Pawar1, BSc; Nieves Gonzalo1, MD, PhD; Jurgen Ligthart1, BSc; Jean de Schepper4, ME; Nico van den Berg
1. Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands; 2. The Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY

Aims: The aim of the pilot SECRITT trial was to evaluate the safety and feasibility of sealing the high risk IVUS and optical coherence

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

tcfavulnerable plaqueself-expanding shieldofdi-oct
Read next article
Multiple complex coronary atherosclerosis in diabetic patients with acute myocardial infarction: a three-vessel optical coherence tomography study

Latest news